Affiliations 

  • 1 From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (Z.-Y.Z., J.A.S.)
  • 2 Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China (W.-Y.Y., Y.W., Q.D., S.L.)
  • 3 Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (A.F.D.)
  • 4 Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.-G.W., Y.L.)
  • 5 Family Medicine & Chronic Care, Qatif Primary Health Care, Ministry of Health, Riyadh, Saudi Arabia (B.A.)
  • 6 Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (S.M.C.)
  • 7 Department of General Medicine, Zaporizhzhia State Medical University, Ukraine (V.V.)
  • 8 Hadassah-Hebrew University Medical Center, Jerusalem, Israel (M.B.)
Hypertension, 2019 11;74(5):1064-1067.
PMID: 31422692 DOI: 10.1161/HYPERTENSIONAHA.119.13206

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.